Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists

Drugs that treat chronic obstructive pulmonary disease by antagonizing the M3 muscarinic acetylcholine receptor (M3R) have had a significant effect on health, but can suffer from their lack of selectivity against the M2R subtype, which modulates heart rate. Beginning with the crystal structures of M...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongtao, Hofmann, Josefa, Fish, Inbar, Schaake, Benjamin, Eitel, Katrin, Bartuschat, Amelie, Kaindl, Jonas, Rampp, Hannelore, Banerjee, Ashutosh, Hübner, Harald, Clark, Mary J., Vincent, Sandra G., Fisher, John T., Heinrich, Markus R., Hirata, Kunio, Liu, Xiangyu, Sunahara, Roger K., Shoichet, Brian K., Kobilka, Brian K., Gmeiner, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2018
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255194/
https://www.ncbi.nlm.nih.gov/pubmed/30404914
http://dx.doi.org/10.1073/pnas.1813988115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255194/
https://www.ncbi.nlm.nih.gov/pubmed/30404914
http://dx.doi.org/10.1073/pnas.1813988115

Ejemplares similares